These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Macular diseases--application of automated static perimetry and optical coherence tomography]. Iijima H Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):943-59. PubMed ID: 11193945 [TBL] [Abstract][Full Text] [Related]
3. [Pathophysiology of macular diseases--morphology and function]. Iida T Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310 [TBL] [Abstract][Full Text] [Related]
4. [Macular diseases in the elderly person]. Matsui M Nippon Ganka Gakkai Zasshi; 1989 Sep; 93(9):883-907. PubMed ID: 2610169 [TBL] [Abstract][Full Text] [Related]
5. The influence of the three color vision-mechanisms on the spectral sensitivity of the fovea. Marré E; Marré M Mod Probl Ophthalmol; 1972; 11():219-23. PubMed ID: 4362471 [No Abstract] [Full Text] [Related]
6. Color vision defects in pigmentary retinal dystrophy. Okajima O; Tanino T; Okamoto M Jpn J Ophthalmol; 1982; 26(3):292-301. PubMed ID: 6984101 [TBL] [Abstract][Full Text] [Related]
7. Progressive human cone-rod dysfunction (dystrophy). Fishman GA Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1976; 81(4 Pt 1):OP716-24. PubMed ID: 1085512 [TBL] [Abstract][Full Text] [Related]
8. Macular function impairment in eyes with early age-related macular degeneration. Midena E; Degli Angeli C; Blarzino MC; Valenti M; Segato T Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):469-77. PubMed ID: 9040480 [TBL] [Abstract][Full Text] [Related]
10. Colour contrast sensitivity in patients with age-related Bruch's membrane changes. Holz FG; Gross-Jendroska M; Eckstein A; Hogg CR; Arden GB; Bird AC Ger J Ophthalmol; 1995 Nov; 4(6):336-41. PubMed ID: 8751098 [TBL] [Abstract][Full Text] [Related]
11. Macular changes in congenital retinoschisis. Tasman W Mod Probl Ophthalmol; 1975; 15():40-9. PubMed ID: 1160914 [TBL] [Abstract][Full Text] [Related]
12. Familial foveal retinoschisis associated with a rod-cone dystrophy. Noble KG; Carr RE; Siegel IM Am J Ophthalmol; 1978 Apr; 85(4):551-7. PubMed ID: 306756 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512 [TBL] [Abstract][Full Text] [Related]
15. Guest editorial: Notes on the macular pigment. Weale RA Ophthalmic Physiol Opt; 2007 Jan; 27(1):1-10. PubMed ID: 17239185 [TBL] [Abstract][Full Text] [Related]
16. Long-term macular function in eyes with central serous chorioretinopathy. Baran NV; Gürlü VP; Esgin H Clin Exp Ophthalmol; 2005 Aug; 33(4):369-72. PubMed ID: 16033348 [TBL] [Abstract][Full Text] [Related]
17. Ophthalmologic findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation: a new type of hereditary metabolic chorioretinopathy. Tyni T; Kivelä T; Lappi M; Summanen P; Nikoskelainen E; Pihko H Ophthalmology; 1998 May; 105(5):810-24. PubMed ID: 9593380 [TBL] [Abstract][Full Text] [Related]
18. [Drusen of the posterior pole and color vision (double color thresholds)]. Vola JL; Gastaud P; Poli C Bull Soc Ophtalmol Fr; 1984; 84(8-9):927-30. PubMed ID: 6085566 [No Abstract] [Full Text] [Related]
19. CNGB3 achromatopsia with progressive loss of residual cone function and impaired rod-mediated function. Khan NW; Wissinger B; Kohl S; Sieving PA Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3864-71. PubMed ID: 17652762 [TBL] [Abstract][Full Text] [Related]
20. Late onset is common in best macular dystrophy associated with VMD2 gene mutations. Renner AB; Tillack H; Kraus H; Krämer F; Mohr N; Weber BH; Foerster MH; Kellner U Ophthalmology; 2005 Apr; 112(4):586-92. PubMed ID: 15808248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]